Definitions of the Clinical Trial PhasesWhen one is considering a clinical trial it is important to know what phase the macular degeneration study is in - especially a Phase I study. In this phase of testing a new drug or treatment the study is evaluating its safety and determining any possible side effects. According to the U.S. National Institutes of Health study phases are defined below: Most clinical trials are designated as phase I, II, III, or IV, based on the type of questions that study is seeking to answer:
Phase IIn phase I clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate:√ its safety √ determine a safe dosage range √ and identify side effects. Phase IIIn Phase II clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.Phase IIIIn Phase III clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000):√ to confirm its effectiveness √ monitor side effects √ compare it to commonly used treatments √ and collect information that will allow the drug or treatment to be used safely In Phase IV clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use. These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.
Go from Clinical Trial Phases to Macular Degeneration Clinical Trials
Would you like to be updated on the latest: √ Macular Degeneration Clinical Trials? 
√ Prevention of Macular Degeneration?√ Tips for Daily Living? √ Food Suggestions for a Macular Degeneration Diet? √ Ideas on Visual Aids to Maximize your Sight? If you said "yes" to any of the above, sign up for my monthly Macular Degeneration News. New! CommentsShare your thoughts about what you just read! Leave a comment in the box below. |
